Formulation and Delivery - Chemical

(W0930-01-01) Are Amorphous Drugs More Compressible Than Their Crystalline Counterparts?

(M0930-01-01) Graphical Design Space for the Primary Drying Phase of Freeze Drying: Factors Affecting the Dried Product Layer Resistance

(T0930-01-03) Intracellular Drug Delivery by Discrete Multiwalled Carbon Nanotubes for MDR Cancer Treatment

(W0930-01-03) Optimization of Phospholipid Based Nano Drug Delivery System of Osimertinib - An In Vitro Drug Release, Ex Vivo Permeability Study

(M0930-01-03) Overcoming Direct Compression Issues in Omeprazole Formulations Using Co-Processed Excipient vs. Wet Granulation

(T0930-01-04) Impact of Penetration Enhancers on Salbutamol Permeation Across Murine Skin

(M0930-01-04) Integrated Approach to Enhance Formulation Robustness in Multiparticulate Formulations

(W0930-01-04) Optimizing Drum Selection for Volumetric-Based Capsule Filling: A Mechanistic Model for Lactose-Based Formulations

(T0930-01-05) Influence of Protective Coating on Extended-Release Pellets and Maintaining Desired Drug Release from MUPS Tablets

(M0930-01-05) Lipid-Stabilized Nanocrystal Vesicles for Cheat-Free Testing of Novel Drugs: The Case of Zuranolone

(W0930-01-05) Oral Targeting of Sensitive Microbiome: A Case from Development of Functional Coated Capsule to Clinical Trial Phase 1b

(W0930-01-06) Application of Acid-Base Supersolubilization (ABS) Principle to Increase Aqueous Solubility of Weakly Acidic Drug Indomethacin and Its Dissolution from ASD Prepared by Hot-Melt Extrusion

(M0930-01-06) Implementing Co-processed API to Enable High-Drug-Load Formulation for Direct Compression

(T0930-03-13) Comprehensive Study on Injectable Capsaicin In Situ Forming Implant for Ultra-Long-Acting Anti-Obesity: Formulation, Characterization, Drug Release, Stability, and Cytotoxicity Studies

(M0930-03-13) Tuning the Organ Selectivity of mRNA Expression through Dendrimer-Based Lipid Nanoparticles

(W0930-03-14) A Journey Through the Development of Cannabidiol Solid Oral Dosage Forms: Balancing API Loading, Physico-Chemical Stability and In Vivo Pharmacokinetic Performance

(M0930-03-14) Styl’One Nano Compaction Simulation Studies and Utilization of a Digital Tableting Platform in Formulation Development

(T0930-03-14) Toward Enhanced Solubility of Cannabidiol: Preparation and Evaluation of Cannabidiol Solid Dispersions Using Vacuum Compression Molding and Cryogenic Milling

(T0930-03-15) Optimization of Donepozil Loaded Liposome for Nose-to-Brain Delivery – An In Vitro Mucoadhesion, and Ex Vivo Permeability Study

(W0930-03-15) Spray Drying of Directly Compressible Amorphous Solid Dispersions (ASDs): Comparison of Different Polymers

(T0930-03-16) Natural-Based ASD Platforms: Enhancing Stability and Bioavailability

(M0930-03-16) Optimizing Storage Conditions to Maintain Chemical Stability and Aerodynamic Performance of Tigecycline Inhalation Powder

(T0930-03-17) Effect of Process Parameters and Buffer Exchange on the Critical Quality Attributes of siRNA Loaded Lipid Nanoparticles

(W0930-03-17) Molecular Structure-Based Predictions of Amorphous Solid Dispersion Formation Are More Accurate When Appropriate Solvent and Faster Solidification Kinetics Are Used

(W0930-03-18) In Vitro Release Method Development for Onivyde^® Using Agilent NanoDis^® System

(T0930-03-18) Targeting Multiple Oncogenic Drivers in NSCLC: Therapeutic Potential of ARV-825 and Gefitinib-Based PROTAC-3 Protein Degraders

(M0930-05-25) Cocrystallization Improves the Tabletability of Ligustrazine Despite a Reduction in Plasticity

(T0930-05-25) Impact of Excipient Types and Drug Loadings on the Tabletability Flip Phenomenon

(W0930-05-26) Preclinical Development of Long Acting Injectables for Delivery of Targeted Protein Degraders

(W0930-05-27) Compaction Simulation as a Risk Mitigation Strategy for Dual Sourcing on Commercial Drug Products

(M0930-05-27) Non-woven Polymeric Fiber Mats for Female-Initiated On-Demand Contraception Without Hormones

(M0930-05-28) Disulfiram-Loaded Metal-Organic Nanoparticles Trigger Immunogenic Cell Death of the Triple-Negative Breast Cancer

(T0930-05-28) Nanoscale Catch-and-Release - Development of Redispersing Solid Nanocrystalline Drug Forms

(W0930-05-29) Comparative Study of Mold Casting and Vacuum Compression Molding Techniques for Fabricating Drug-Loaded Microneedle Arrays: Precision, Drug Loading, and Performance Evaluation

(W0930-05-30) Broad Applicability of a Model for Predicting Tabletability of Mixtures from Those of Individual Components

(T0930-05-30) Formulation Development and Optimization of Fenofibrate Nanosuspension Coated Microcrystalline Cellulose Based Granules

(M0930-05-30) Sotorasib Nanosuspension: A Patient-Centric Approach to Improve Oral Absorption and Overcome Limitations Associated with Current Treatment

(W0930-07-38) An Efficient Strategy to Overcome Poor Flow and Compressibility Issues of Lamivudine for a Robust Tablet Formulation Using a Coprocessed Excipient

(M0930-07-38) Evaluating Mucoadhesion of Polymer Films Using Wax Substrates with Mucin Coating

(T0930-07-38) Understanding Dibasic Calcium Phosphate Impact on Chemical Stability - Trends in Immediate Release Tablet Formulations

(W0930-07-39) Development and Characterization of Cannabidiol and Rho Kinase Inhibitor Combination Formulations for Ophthalmic Use

(T0930-07-39) Improving the Solubility of Apixaban and Preparation Sustained-Release Tablets Through a Solidified Self-Microemulsifying Drug Delivery System

(M0930-07-40) Application of Binder Jetting to Develop 3D Printed Modified Release Tablets

(T0930-07-40) Soft Foods as Alternative Reconstitution Vehicles for Sodium Oxybate Extended-Release Drug Product (LUMRYZ^TM)

(M0930-07-41) Development and Evaluation of Buprenorphine Sublingual Formulation for the Treatment of Neonatal Opioid Withdrawal Syndrome

(W0930-07-41) Evaluation of Plasticizer and Stabilizer Effect on Drug Release Profiles of Taste-Masked Vardenafil MUPS ODT

(T0930-07-41) Pulmonary Delivery of Trametinib-Encapsulated Nanostructured Lipid Carriers for Non-Small Cell Lung Cancer

(M0930-09-48) Data-Driven Prediction of Translational Formulation Strategies for Poorly Water-Soluble Drug Molecules: Machine Learning to Minimize Trial and Error in Early Formulation Development

(W0930-09-48) Impact of Excipient Purity on the Stability of Chemotherapy Drugs

(M0930-09-49) Formulation Development of Simvastatin Self-Emulsifying Drug Delivery System Using Hot Melt Extrusion

(T0930-09-49) Understanding the Effect of Plasticizers in Film Coat Materials on the Physical Stability of Amorphous Solid Dispersions

(T0930-09-50) Aerodynamic Performance of Inhalable Zinc Oxide Microparticles as Carriers for Dry Powder Inhalers

(W0930-09-50) Determining the Most Suitable Gelling Agent for Topical Semi-Solid Formulation Development- An Investigation into the Physical Robustness of Various Gelling Agents

(M0930-09-50) Predicting Filaments Behavior in Milling and Printing via 3 Point Bend Test

(T0930-09-51) Enhanced PBPK-Based In Vitro to In Vivo Extrapolation Method to Support the Development of Pulmonary Drug Products

(W0930-09-51) Evaluating Formulation Platforms for Poorly Soluble APIs to Mimic PROTACs

(M0930-09-51) Improvements in Liposomal Manufacturing Technology

(T0930-09-52) Biphasic Dissolution Rate and Absorption Study of Adefovir Dipivoxil and Its Cocrystals under Biorelevant Conditions

(M1030-01-01) Engineering of Layer-By-Layer “Smart” Acetate Coated Paclitaxel Loaded Polylactic-Co-Glycolic Acid Nanoparticles to Treat Prostate Cancer In Vitro

(W1030-01-01) Nitrosamine Mitigation Case Study: The Importance of Utilizing a Multi-Pronged Approach to Reduce Impurities

(T1030-01-01) Vegetarian Softgels Using SeaGel® Technology for Pharmaceutical Applications

(M1030-01-02) Development of Tretinoin-loaded Lipid Nanoparticles for Topical Drug Delivery

(W1030-01-02) Harnessing the Potential of Self-Assembled Hyaluronic Acid Nanoparticles for Tumor Targeted Co-Delivery of Betulinic Acid and Paclitaxel

(M1030-01-03) Reverse Engineering of Nexplanon^® Contraceptive Implant: Physicochemical Properties and In Vitro Drug Release

(M1030-01-04) Development of Extrusion-Based 3D Printed Hydrophilic Polymeric Transdermal Films of Pramipexole Dihydrochloride for Parkinson’s disease

(T1030-01-04) Formulation Development and Characterization of Isoniazid-Pyridoxine Combination Gummies Using an Extrusion-Based 3D Printer

(W1030-01-04) In Vitro Characterization and In Vivo Efficacy Study of a 2nd Generation Synthetic Lung Surfactant (SLS) Excipient Enhanced Growth (EEG) Dry Powder Formulation and Device

(M1030-01-05) Novel Combination Approach to Enhance Solubility and Permeability of Pazopanib Using Phospholipid Complex and a Bioenhancer

(W1030-01-05) Sustainable Development of a Nanosystem for the Co-encapsulation of Apigenin and Curcumin for Pharmaceutical Applications

(W1030-01-06) Facile and Tunable Nanoparticle Delivery with Granular Hydrogels

(M1030-01-06) Supersolubilization and Amorphization of a Weakly Acidic Drug, Flurbiprofen, by Applying Acid-Base Supersolubilization (ABS) Principle

(W1030-03-13) Role of Polyethylene Glycol and Propylene Glycol in Modulating the Spreadability and 3-D Structure of a Carbomer Based Nasal Gel

(T1030-03-13) The Selection of Microcrystalline Cellulose Based Excipient in Extrusion Spheronization

(T1030-03-14) Novel Microemulsion-Based Fenofibrate Eyedrop for Treating Nitrogen Mustard-Induced Corneal Injury

(M1030-03-15) Formulation-Related Influences on the Ex Vivo Permeation of Lidocaine Hydrochloride Films

(W1030-03-15) The Evaluation of Methacrylic Acid Copolymer as a Direct Compressible Excipient for Erosion Based Sustained Release Matrix Tablets

(T1030-03-16) Baru Nuts and Chia Seeds Extracts as Stabilizer in Nanostructured Formulation for Optimized Antifungal Drug Delivery of Fluconazole

(M1030-03-16) Development and Characterization of PLGA Tip-Loaded Polymeric Microneedles for the Sustained, Week-Long Release of a Lipophilic Molecule-Carfilzomib

(W1030-03-17) Amorphous Stabilization of BCS II Drugs Using Mesoporous Silica

(M1030-03-17) Bioresponsive Hydrogel Compositions Designed to Fortify Natural Contraceptive Barrier Properties of the Cervicovaginal Environment in Humans

(W1030-03-18) Exploring the Potential of Inhaled Clofazimine Liposomes for Mesothelioma Treatment

(W1030-05-25) Targeted Peptide Dual Drug Conjugate for the Treatment of Glioblastoma

(T1030-05-26) 3D-Printed Short Nanofibers/Hydrogel-Based Vaginal Films as a Novel System for the Delivery of Anti-HIV Microbicide Drugs

(W1030-05-26) Transdermal Lamivudine Deep Eutectic Systems for the Long-Term Management of Pediatric Hepatitis B Virus and HIV Infections

(W1030-05-27) Comparison of Two Self-Nanoemulsifying Drug Delivery Systems Using Different Solidification Techniques for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib

(T1030-05-27) Transferrin Conjugated Liposomes with Rho-Kinase Inhibitor for Treating Fuchs Endothelial Corneal Dystrophy

(T1030-05-28) Characterizing the Effects of a Novel Surfactant on Growth Inhibition and Preservation of Different Bacterial Species

(M1030-05-28) In Vitro and In Vivo Evaluation of Topical 4-phenylbutyric Acid Microsponge Formulation as a Potential Antidote Against Arsenical-Induced Skin Injury

(W1030-05-28) Liposomal Amodiaquine for Localized Therapy of Non-Small Cell Lung Cancer (NSCLC)

(T1030-05-29) Improving the Drug Release of Clofazimine by Developing Amorphous Solid Dispersions via Hot-Melt Extrusion Using the Acid-Base Supersolubilization Principle

(M1030-05-29) Preparation and Characterization of Pregabalin Loaded Liposomes for Topical Drug Delivery: Utilizing the Novel Platform Technology for the Effective Treatment of Neuropathic Pain Management

(W1030-05-29) Topical Cream Formulation of Integrated Stress Response Inhibitor (ISRIB) for the Potential Treatment of Chemical Warfare Skin Injury: Effect of Chemical Enhancers, Concentration, and pH

(T1030-05-30) Moisture Sorption of Microcrystalline Cellulose

(W1030-05-30) One Like the Other? A Novel In Vitro Release Method to Ensure Proper Drug Release of Extended-Release Mini-Tablets for Paediatric Use

(W1030-07-38) Development of Targeted Nanovehicles to Deliver Biomolecules to Cerebrovascular Endothelium

(M1030-07-38) Evaluation of In-Use and Accelerated Stability Studies of Platelet Aggregation Inhibitors: Clopidogrel Hydrogen Sulfate

(T1030-07-38) SubQ Environment Impact on In Vitro Drug Release of PLGA Microspheres

(M1030-07-39) Comparative Analysis of Co-Processed AVICEL DG® vs Individual Microcrystalline Cellulose and Anhydrous Dicalcium Phosphate in Tablet Formulation

(T1030-07-39) Melt Granulation Using a Planetary Triple Mixer for the Metformin Controlled-Release Tablet Containing Ethyl Cellulose and Hydrogenated Vegetable Oil (HVO)

(W1030-07-39) Mesenchymal Stem Cell-Based Combination Therapy for Enhanced Efficacy Against Patient-Derived Lung Cancer Xenograft Model

(M1030-07-40) Drug Release Rate Characterization of Double Nanoemulsions (W1/O/W)

(T1030-07-40) New Direct Compressible Mannitol for Minitablets Industrial Scale Manufacturing

(W1030-07-40) Using Gravitational Force to Determine the Minimum Concentration of Various Gelling Agents Needed to Maintain Homogeneity of Micronized API in Suspension

(T1030-07-41) Development of N-Salsalate Parenteral Nanosuspension: A Safe and Effective Analgesic for Post-Operative Pain Management

(T1030-09-48) Understanding Critical Quality Attributes of Gelatin Coated Miconazole Nitrate Vaginal Inserts and Suppositories

(T1030-09-49) Analyzing the Characteristics of HME Extruded Material in Pharmaceutical 3D Printing: Formulation, Printability, and Dissolution Study

(M1030-09-49) Selective Laser Sintering 3D Printing for Improved Solubility of Indomethacin: A Study on Amorphous Drug Conversion

(T1030-09-50) Amorphous Solid Dispersions of Spray Dried Celecoxib-SBE7βCD-Polymer Ternary Complexes: Enhancements on Intrinsic Dissolution, Crystallization Prevention, and Stabilizing Effects.

(W1030-09-50) Development of Colon-Targeting UniORV Containing Salazosulfapyridine Composed of Chitosan/Alginate-Based Matrix

(M1030-09-50) Rediscovery of Paclitaxel: A Novel Oral Paclitaxel Softgel Capsule Product for Improving Cancer Therapeutics

(M1030-09-51) Development of 3D Printed Oral Disintegrating Tablets of Oxcarbazepine Using Co-Processed Excipient

(W1030-09-51) Early-Phase Form Screening of Solubility-Limited Drugs Via In Vitro Characterization and In Silico Modeling

(T1030-09-51) Simplification Study of Feed System in HPMCAS Dry Coating

(M1030-09-52) Development of a Self-Emulsifying Drug Delivery System (SEDDS) of Fenofibrate Using ZoomLab^TM

(W1030-09-52) Development of L-dopa-Loaded Nanofiber for Transbuccal Drug Delivery

(T1030-09-52) Weekly Apixaban Transdermal Delivery System

(M1030-10-54) Use of Povidones and Copovidones as Solubility Enhancers for Itraconazole Using Hot Melt Extrusion

(M1030-10-55) Factory-on-a-Pill – a Digital Pill Concept to Deliver Medicines in Space

(M1030-10-56) Development and Validation of Biorelevant Multimodal In Vitro Characterization Techniques for Assessing the Adhesiveness Performance of Transdermal Patches

(M1030-10-57) A Solution that Improves the Poor Soluble API Dissolution by Using Porous Calcium Silicate FLORITE^®

(M1030-10-58) A Comparative Study of Hypromellose Acetate Succinate and HPMCP by Spray Drying Method and Top Spray Method for Solubility Enhancement

(T1030-10-59) Unexpected Nucleation of Amorphous Terfenadine at a Much Lower Temperature than the Glass Transition Temperature and Its Impact on Dissolution Behavior and Physical Stability

(T1130-01-01) Active Targeting to the Hepatocytes: How Important is Tailoring the Liposomes and Physicochemical Properties and Surface Modification in Targeting the Hepatocytes?

(W1130-01-01) Development of an Intraocular In Situ-Forming Implant of a Novel Compound to Target the Retina in a Rabbit Model

(M1130-01-01) The Importance of Surface Composition and Wettability on the Dissolution Performance of High Drug Loading Amorphous Dispersion Formulations

(T1130-01-02) Application of Knowledge Based Expert System to Predict API-Excipient Incompatibilities

(W1130-01-02) Bioequivalence Approaches Utilized in Generic Drug Applications for Topical Drug Products Applied to the Skin

(M1130-01-02) Preparation and Evaluation of Pramipexole Transdermal Patch: In Vitro and In Vivo Study

(M1130-01-03) Exploring the Pharmacological Properties of Spondias mombin L. Seed Extract

(W1130-01-03) Simulation of Variable Fasted Gastric Motility and pH as a Key to Understand Contrasting Properties of Immediate Release Pellet-Filled Capsules and Bare Pellets

(W1130-01-04) Predicting Hydroxypropyl Methylcellulose-Controlled Release Matrix Performance with Powder Dissolution Temperature

(M1130-01-04) Utilizing Hydroxypropyl Methylcellulose (HPMC) and Carrageenan in Nasal Spray Gel with Andrographis paniculata Extract for COVID-19 Prevention

(M1130-01-05) Novel Cell-Penetrating Peptide-Based Therapy for Treating Atopic Dermatitis

(T1130-01-05) Platform Technology for Introducing Liquid Solubilisers in Tablet Formulations

(W1130-01-05) Preformulation Studies to Guide the Processing of Triamcinolone Acetonide by Hot-Melt Extrusion

(W1130-01-06) DoE-Enabled Development of Osimertinib-Encapsulated PLGA Nanoparticles for the Treatment of Non-Small Cell Lung Cancer

(T1130-01-06) Nystatin-Loaded Microneedles via MeltPreP Vacuum Compression Molding for Prolonged Defense Against Candida albicans

(M1130-01-06) Role of Temperature in the Formation of Solid Micellar-Size Nanoparticles of Nonionic Polyoxyethylated Amphiphiles

(W1130-03-13) Powerful Tools for Precise Engineering of Viatel^TM Diblock Nanoparticle Size: Polymer and Solvent Structure

(M1130-03-14) Development and Characterization of Preservative Free Ocular Formulation

(T1130-03-14) Development of Dexibuprofen Loaded Dissolving Microneedle for Improved Permeability and Bioavailability

(W1130-03-14) Microarray Patches with Cyclodextrin-Carvedilol Complex for Heart Failure Treatment

(W1130-03-15) A Biorelevant In Vitro Methodology for Assessing the Efficiency and Safety of Activated Charcoal in the Management of Drug-Induced Intestinal Dysbiosis

(T1130-03-15) Investigations on Formulation and Process Effects on Avicel^® RC-591 Rheological Performance in Suspensions

(M1130-03-15) Utilization of Gelatin-Oleic Acid Conjugate Solid Dispersion for Enhanced Stability of Water-Labile Drug

(W1130-03-16) Development of Novel Local Anesthetics-Clay Composite Formulations to Improve Stability and Reduce Onset Time

(T1130-03-17) Oral Cavity Permeation of Buprenorphine Across In Vitro Models of the Buccal and Gingival Mucosa

(W1130-03-18) Formulation Development of Famotidine Floating Tablets Using Hot-Melt Extrusion and 3D Printing Techniques

(M1130-03-18) Model-Informed Approach for Formulation Development of Extended-Release Phenserine Tablets to Mitigate pH-Dependent Degradation

(M1130-05-25) Preclinical Evaluation of Soluplus-Based Amorphous Solid Dispersion of Alectinib: Bioavailability Enhancement and IVIVC Model Establishment

(T1130-05-26) Iron Oxides in Titanium Dioxide-Free Coatings Protect Photolabile Active Pharmaceutical Ingredients in Oral Solid Dosage Forms

(T1130-05-27) Bioequivalence Recommendations for Tretinoin-Containing Topical Products

(T1130-05-28) ROS-Responsive Polymeric Chloroquine Nanogel as Oral Maintenance Therapy for Inflammatory Bowel Disease

(M1130-05-29) Rapid Detection of Formulation Stability for Fast Product Development

(T1130-05-29) Sodium Alginate-Based Bio-Adhesive Hydrogel: A Hemostatic Agent, Endoscopically Deliverable to the Gastrointestinal Resection Site

(M1130-05-30) Colon Targeted Delivery of Nanosuspension Coated Granules of Albendazole tor the Localized Treatment of Colorectal Cancer

(T1130-07-38) Deformable Polydopamine Nanocapsules for siRNA Delivery to Solid Tumors

(W1130-07-38) Sustainable Alternatives to Petroleum-Derived Excipients in Topical Creams

(T1130-07-39) Development of Novel Combination Therapy containing Lobeglitazone and Its Clinical Studies in Patients with Poorly Controlled Type 2 Diabetes

(W1130-07-39) Investigating ISFIs with PLGA as Sustained Release Formulations for the Urinary Bladder

(M1130-07-39) Revolutionizing Drug Formulations: Delayed Release and Sustained Release Using Hypromellose 2208 Types and Hypromellose Acetate Succinate

(M1130-07-40) Bilayer Microneedle Array Patch for Transdermal Delivery of Novel Capsid Inhibitor Lenacapavir to Mitigate the Risk of Pediatric HIV Infection

(T1130-07-40) Development of Mathematical Function Control-Based 3D Printed Tablets and Effect on Drug Release

(W1130-07-40) Integrating Bioaccessibility Data from the Tiny-TIMsg into a Physiologically Based Biopharmaceutics Model (PBBM) of a BCS Class IV Compound to Predict Pharmacokinetic (PK) Performance

(W1130-07-41) Biorelevant Dissolution Testing for Protein-Based Amorphous Solid Dispersions: Improving In Vitro Formulation Ranking

(T1130-07-41) Novel 3D Printed Polypill for Diabetes Mellitus Management and Associated Cardiovascular Risks

(M1130-07-41) Photonic Formulations of Hydroxypropyl Cellulose – Study of Mixtures with a Pharmaceutical Potential

(T1130-09-48) Rapid Production of Personalized Breast Cancer Medicines for Inclusion in a Clinical Trial Using a Novel Pharmaceutical 3D Printing Platform in a Hospital

(T1130-09-49) Development of In Vitro Skin Permeation Testing Method to Assess the Bioequivalence of Topical Roflumilast Cream Formulations

(W1130-09-49) Tyrosine Kinase Inhibitor Loaded Inhalable Liposomal Formulation for Non-Small Cell Lung Cancer

(W1130-09-50) Assessment of In Vitro Skin Permeation of Ruxolitinib of OPZELURA (Ruxolitinib Phosphate) Topical Cream, EQ 1.5% Base to Support a Demonstration of Bioequivalence

(T1130-09-50) Biopharmaceutical Tools for De-risking Paediatric Formulation Development

(T1130-09-51) Accelerating SEDDS Formulation Development with Machine Learning

(W1130-09-51) Development of Crystalline Linsitinib Formulations for Local Reduction of Adipose Tissue

(M1130-09-51) Engineered Cocrystals to Improve Solution Behavior of Poorly Soluble NAR

(T1130-09-52) A Modelling and Simulation Assessment of Steady State Apixaban Delivered from a Weekly Transdermal Patch

(M1130-09-52) Inclusion Complexes of Posaconazole with Hydroxypropyl- and Sulfobutylether-β-Cyclodextrins for Intravenous Injections: Formulation and Stability Studies

(W1130-09-52) Insights in Designing Osmotic Modified Release Delivery Platform for Solid Dispersions: Challenges and Conception

(T1130-09-53) Smart Formulating of Pharmaceutical Emulsions Using HLD-NAC Theory

(M1130-09-53) Thermoresponsive Polymeric Prodrug of Hydromorphone (ProGel-HMP) Provides Sustained Relief to Skeletal Pain in a Rodent Model of Femur Fracture

(T1230-01-01) Exploring Rifamycin Cytotoxic Potential in 2D and 3D Cancer Cell Models Using Liposomes as Delivery System

(W1230-01-01) Understanding the Role of Acidic pH Modifiers in Achieving pH-Independent Release from Extended-Release Matrix Tablets of Weakly Basic Drugs

(T1230-01-02) Effect of Mixing Time and Mixing Process on Lubricant Sensitivity of Excipients with Different Deformation Characteristics

(W1230-01-02) Novel Use of Excised Bovine Stomach to Study Mucoadhesive and Rheological Synergism Properties of Gastro-Retentive Antacid Formulations

(M1230-01-02) Redox-Responsive Fattigated Nanoparticles Potentiate Lipid Accumulation and Controlled Doxorubicin Release for Boosting the Anti-Cancer Activity

(T1230-01-03) A High Oral Bioavailable Berberine-Lornoxicam Cocrystal with Improved Caco-2 Permeability, Tunable Dissolution, and Improved Taste

(M1230-01-03) Dual-Drug Ionic Liquid Complex Dextromethorphan Naproate with Enhancement of Physico-Chemical Properties than Parent Molecules

(W1230-01-04) A Hybrid Mechanistic Model for Predicting Milling Performance of Roller Compacted Ribbons

(T1230-01-04) Development and Characterization of Solid Lipid Nanoparticles Encapsulating Curcumin for Targeted Therapy of Mucosal-Barrier Associated Cancers

(M1230-01-04) Week-Long Transdermal Delivery of an Anxiolytic Drug Using Tip-Loaded PVA Microneedles

(T1230-01-06) A Novel Approach Using an Organic Phase Nanosuspension to Enhance Drug Loading of Hydrophilic Compounds in Nanoparticles

(T1230-03-13) Enhancement of Transdermal Delivery for β-Carotene as a Treatment of Skin Cancer: Quality by Design Optimization of Microemulsion Formulation

(T1230-03-14) Development of Soluble Microneedles Containing Ketoprofen with Improved Permeability and Bioavailability

(W1230-03-14) Impact of Lubricant on Functional Tablet Coatings Containing Pectin

(M1230-03-15) Coamorphous Nanoparticles Produced by Co-precipitation of Two Drugs Based on Liquid-Liquid Phase Separation: Improved Solubility and Membrane Permeability

(T1230-03-15) Formulation and Evaluation of Solid Self-Micro Emulsifying Drug Delivery System (S-SMEDDS) of Celecoxib

(W1230-03-15) Preparation of Lurasidone Hydrochloride Nanoparticles and Enhanced Bioavailability

(T1230-03-16) Development and Evaluation of a Drug Delivery System Based on Polymeric Nanoparticles of Nitazoxanide

(M1230-03-16) Enhanced Skin and Follicular Delivery of Tazarotene from PLGA Nanoparticles for the Treatment of Acne and Psoriasis

(T1230-03-17) Development of Long-Acting Decoquinate Nanocrystal-Based Formulations as a Chemical Vaccine for Malaria

(W1230-03-17) Optimizing the Process Parameters for Utilizing Hot-Melt Extrusion Technology in the Development of Cannabidiol Nano-Structured Lipid Carriers

(M1230-03-18) Multimodal Immunogene Therapy via Nanoparticle Delivery System

(M1230-05-25) A Molecular Dynamics Study of the Impact of Water Content on Pre-nucleation Aggregates in Amorphous 2-Phenylamino Nicotinic Acid

(T1230-05-25) How are Medicines Administered to Pre-school Children? Current Status of a Global Survey on the Use of Dosing Vehicles

(T1230-05-26) Low Nitrite-Controlled Release Formulations for Water-Soluble Drugs

(M1230-05-26) Manufacturability, Stability, and In Vitro Release of 60% Drug Loaded Amorphous Nanoparticle Tablets of a BCS IV Compound: ABT-530

(T1230-05-27) Impact of Polymer Residual Content on the Quality Characteristics of Risperidone PLGA Microspheres

(T1230-05-28) Assessing Impact of Core Components, Coating Formulation and Functional Packaging on Product Quality of Nutraceutical Tablet Dosage Forms

(M1230-05-28) Improved Dissolution and Pharmacokinetic Behaviors of Zerumbone upon Solid Lipid Nanoparticle Approach

(M1230-05-29) Employing Hot Melt Extrusion and Vacuum Compression Molding to Develop Cannabidiol Solid Sedds for Improved Solubility

(T1230-05-30) Controlled Release Mannose and RVG-9R Functionalized PLGA Nanoparticles for Targeting the Brain Viral Reservoir for the Management of HIV Associated Neurocognitive Disorder

(M1230-05-30) Exploration of the Utility of Bentonite for Developing a Pediatric Formulation of Everolimus

(T1230-07-37) Alternative Aqueous Dispersion System for Enteric Coating of Ibuprofen Tablets

(W1230-07-38) Ethanol Solubility of Rate Controlling Polymer in Modified Release Formulation Can Impact Alcohol Dose Dumping: An Assessment Through Principal Component Analysis

(M1230-07-38) Improved Ibuprofen Tablet Formulation Using Co-Processed Excipients Containing Polyethylene Glycol 8000

(M1230-07-39) A Comparative Approach in the Evaluation and Optimization of Enteric Coating for Tablet Formulation

(W1230-07-39) Lipid Nanoparticles Particle Size Control: Effect of Buffer and Linear vs Circular mRNA

(T1230-07-40) Evaluating the Gastric Integrity of Capsugel® Enprotect® Capsules in Fasted and Fed State Using the Dynamic Gastric Model (DGM)

(W1230-07-40) Expanding the Design Space of Swellable Core Technology (SCT) for Delivery of Higher Doses and Patient Centric Dosage Form

(M1230-07-40) Optimization of Excipients Attributes of Immediate Release Tablet Formulation Using Quality by Design

(T1230-07-41) Assessing the Impact of Cryo-Freezing in Different Topical Formulations

(M1230-07-41) Investigation of the Dermal Delivery of Benzoyl Peroxide from Topically Applied Formulations In Vitro

(W1230-07-41) Novel Inter-Polymer Complexes in the Development of Spray-Dried Dispersions: A Computational and Experimental Study

(M1230-09-48) Role of Low Nitrite (LN) Excipients in Mitigating N-Nitrosamine Drug Substance-Related Impurity (NDSRI) Formation in Drug Products

(T1230-09-49) Complex of Paclitaxel Mesoporous Silica Nanoparticles with Curcumin, TPGS Exerts Higher Anticancer Potency in B16F10 Melanoma

(M1230-09-49) Microneedle-Based Co-Delivery System for Naproxen Sodium and Caffeine in Migraine Therapy

(W1230-09-49) Optimization of Ocular Mini Tablet Formulations: A Comparative Study of 3D FDM Printing and Vacuum Compression Molding Methods for Sustained Drug Release

(T1230-09-50) Downstream Processing of HPMCAS-Based Amorphous Solid Dispersion (ASD) of Fenofibrate: From Hot-Melt Extrudate to Tablet

(W1230-09-50) Preparation and Characterization of an Ultraflexible Liposomal Gel for Transdermal Delivery of a Novel Pan-RAS Inhibitor for Melanoma

(M1230-09-50) The Hidden Potential: Enhancing Doxycycline Dissolution and Aerodynamics with HPMC and Gelatin for Pulmonary Drug Delivery

(W1230-09-51) A Mucoadhesive Composition for Pulmonary Delivery of mRNA Lipid Nanoparticles

(T1230-09-51) FDA Perspective on Dissolution Testing for Development of High-Risk Oral Drug Products Containing Amorphous Solid Dispersions

(M1230-09-51) Formulating Sustainable Solid Oral Tablets by Employing Digital Tools and Co-Processed Excipients

(T1230-09-52) Exploring Particle Behaviour during Dissolution Testing of Long-Acting Injectable Suspensions - A Potential Role for Image Analysis

(W1230-09-52) Using PBPK to Establish In Vitro In Vivo Relationship for Budesonide Delayed Release Oral Drug Product

(W1230-10-54) Development of Robust and Customizable Zero-Order Release Push-Pull Osmotic Tablets

(W1230-10-55) In Vivo Evaluation of Cocoyl Caprylocaprate on API Skin Permeation and Bioavailability

(W1230-10-56) Efficient Manufacturing of Omeprazole Modified-Release Minitablets Using “All-in-One” Co-Processed Excipient and Talc-Free Aqueous Coating System

(M1230-10-56) Sodium Stearyl Fumarate vs. Magnesium Stearate: Understanding the Mechanism of Over-Lubrication

(T1230-10-57) Biorelevant Dissolution Testing in Tiny-TIMsg to Improve Predictivity of Food Effect on Oral Delivery of BCS Class II Compound

(W1230-10-57) Efficient Development of High Drug-Loaded Posaconazole Tablets Enabled by Amorphous Solid Dispersion

(M1230-10-57) Formulation of an Oil-in-Hydrogel Anti-Adhesion System for Sustained Release of Liposomes-Encapsulated 5-Fluorouracil

(W1230-10-58) A Stable and Scalable Gemcitabine and Paclitaxel Drug Combination Nanoparticle (DcNP) Exhibits Long-Acting Pharmacokinetics and Breast Tumor Regression in an Orthotopic 4T1 Mouse Model

(T1230-10-58) Evaluation of Mitigation Approaches for Nitrosamine Formation in Binary Blends

(T1230-10-59) Elucidation of Drug Release Mechanisms of Quetiapine Fumarate Extended-Release Tablets Via Real Time Surface Dissolution Imaging

(M1330-01-01) The Anti-Colon Cancer Potential of Succinylated Curcumin Encapsulated in Mannosylated Chitosan

(T1330-01-01) Use of Thermo-Responsive Biodegradable Triblock Copolymers in Design of a Novel Delivery Formulation for Intravitreal Injection of Pirfenidone

(M1330-01-02) Enhanced Permeability and Stability of Self-Assembled Fatty Acid-Conjugated Peptide Drug Nanoparticles for Oral Delivery

(T1330-01-03) Development of Hypoxia-Responsive Polymersomes for Drug Delivery to Pancreatic Ductal Adenocarcinoma (PDAC) Cells

(M1330-01-05) Is a Minimally Invasive Amphotericin B Treatment Feasible? Nanocrystals-Loaded Microneedles for Cutaneous Leishmaniasis

(T1330-01-06) A Novel Liposome Delivering Adavosertib for Ovarian Cancer Treatment

(M1330-01-06) Formulation of a Poorly Soluble Antiviral Drug as Microparticle Powder for Nasal Breath Intake Against Respiratory Infections

(T1330-03-14) Comparison of Two Types of Ketoprofen Loaded Solid Dispersion and Solid Self Nano-Emulsifying Drug Delivery System: Improved Solubility and Oral Bioavailability

(M1330-03-14) Mesenchymal Stem Cell-Based Drug Delivery Approach for Effective Management of Pancreatic Cancer

(T1330-03-15) Optimization of Spray-Dried Amorphous Solid Dispersions (ASDs) for Capsule Administration

(M1330-03-16) From Desired Dissolution Profile To Particle Size Distribution: Solving The Inverse Problem

(T1330-03-17) Developing Biosustane SAIB NF as a Novel Excipient for Oral Dosage Forms

(M1330-03-17) Development, Characterization, and In Vitro Digestion of C-phycocyanin-Whey Protein Isolate-Zein Nanoparticles for Pharmaceutical Applications

(M1330-03-18) Can Individual Taste Perceptions Bias the Results of Taste Panel Studies? Lessons Learned from an In Vivo Investigation with Paediatric ODMTs

(T1330-03-18) Taking Medicines the Milky Way: How Does Milk Affect Disintegration of Mini-Tablets with a Taste-Masking Coating?

(M1330-05-25) Generalization of the Tabletability Equation for Describing Powder Properties as a Function of Compaction Pressure

(T1330-05-26) Development and Characterization of Dose Flexible Printlets of Lamivudine Using Binder Jet – 3D Printing

(T1330-05-27) Co-delivery of Curcumin and Sildenafil Citrate with 3D-Printed Collagen-Chitosan Scaffolds for Enhanced Wound Healing

(M1330-05-27) Design of Foamable Microemulsions for Vaginal Antifungal Drug Delivery

(M1330-05-28) Application of Acid-Base Supersolubilization Principle to Telmisartan, a Weakly Acidic, High Melting, and Low Solubility Drug, to Lower Hot Melt Extrusion Temperature and Increase Drug Dissolution

(T1330-05-29) Selection of Excipients for Levodopa-Loaded Microparticles Prepared Using Spray-Drying

(M1330-05-29) Self-Nanoemulsifying Systems Containing Ionic Liquids of Rilpivirine for Improved Oral Bioavailability and Penetration in the HIV Sanctuary Sites

(T1330-05-30) Permeability Enhancer Incorporated Oral Nano-Suspension of BRD4 Degrader for Glioblastoma Treatment

(T1330-07-38) Impact of Oleic Acid Based Nanoemulsions on Corneal Integrity: An Ex Vivo Study Using Rabbit Corneas

(M1330-07-38) Proof of Concept In Situ Salt Formation during Amorphous Solid Dispersion Fabrication to Improve Physical Stability and Drug Release Performance

(T1330-07-39) Hot Melt Extruded Amorphous Solid Dispersions Containing Lumefantrine and Soluplus

(M1330-07-39) Optimized Prime: A Transformative LNP Composition for Scalable RNA Vaccines

(M1330-07-40) Development of Caffeine Customized-Release Tablets Using 3D Printing System and IVIVC Prediction

(M1330-07-41) Manufacturing and Formulation Impacts on Colloidal Speciation in ASD Dosage Forms

(T1330-07-41) Toward High Drug-Loaded Pellets to Overcome Dysphagia: Safety and Acceptability of Placebo Pellets Co-Administered with a Swallowing Gel in Healthy Volunteers

(T1330-09-48) Controllable Microfluidic Synthesis of Drug-Loaded PLGA/PEG Nanoparticles Using DoE Approaches with Versatile Flow Streams

(M1330-09-49) Eliminating Operator Dependence from Gelling Agent Addition - Improving the Robustness and Processing Time of Semi-Solid Dosage Forms Without Impacting the Viscosity or Aesthetics

(T1330-09-49) In Vivo and Biopredictive In Vitro Dissolution Testing of Dexamethasone Intravitreal Implants in Rabbits

(M1330-09-50) Bioequivalence Prediction with Dissolution-Permeation Set Up and tinyTim for Amorphous Solid Dispersion Manufactured by a Novel Co-precipitation Process and Spray Drying

(T1330-09-50) Exploratory Studies of Curcumin Loaded PCL Microparticles Produced Using a Novel Technology- SMART

(T1330-09-51) Klucel Fusion™ HPC Facilitating Continuous Melt Granulation in a GEA ConsiGma® Granulator

(M1330-09-51) Synthesis and Characterization of Nanostructured Lipid Carriers (NLC) with Bile Salts: Sodium Deoxycholate (SDC), Sodium Deoxyglycholate (SDGC) and Sodium Deoxytaurocholate (SDTC)

(T1330-09-52) Co-Formulation of Vinorelbine and Doxorubicin into Liposomes for the Treatment of Non-Small Cell Lung Cancer

(M1330-09-52) Non-Destructive Quality Control of Medicines Produced through 3D Printing in a Hospital Using Two Handheld Spectrometers

(T1430-01-01) Preparation of a Modified Release Dosage Form of Diltiazem Hydrochloride Using Cation Exchange Resins

(T1430-01-02) Development of an Extended Action Fostemsavir (FTR) Lipid Nanoparticle (LNP) Antiretroviral Therapy

(M1430-01-02) Mixture of Immediate-Release Beads and Controlled-Release Beads to Form Sodium Oxybate Extended-Release Drug Product (LUMRYZ^TM)

(M1430-01-03) Development of a Coextrusion Process to Prepare Etonogestrel Long-Acting Implant

(T1430-01-03) Development of Film-Forming Gel Containing Ketoprofen with Improved Skin Permeability and Bioavailability

(T1430-01-04) Exploration of Antioxidant Activity and Conversion Potential of Cosmeceutical Actives: Ascorbic Acid and Its Derivatives

(M1430-01-04) Formulation and In Vitro Evaluation of Carrageenan Based Gummies

(T1430-01-05) Formulation Development of Novel PLGA-Based Long-Acting Monolithic Implant

(M1430-01-06) Formulation Effects of Marketed Oral Cavity Products on In Vitro Buccal Permeability

(T1430-01-06) Preparation and Characterization of Diclofenac Loaded Polymeric Nanoparticles from Mango Seed Kernel Starch

(M1430-03-14) Intravitreal Delivery of Anti-Inflammatory Agents via Thermo-Responsive Gel-Forming Biodegradable Triblock Copolymers

(M1430-03-15) Physicochemical Properties and Controlled Peptide Drug Release via Hydrophobicity Modulation of Albumin-Oleic Acid Conjugate

(T1430-03-16) Development of Microemulsion Formulations with D-Limonene and Terbinafine Hydrochloride for Treatment of Cutaneous Fungal Infections

(T1430-03-17) Development of Microneedle Array Patch Systems for Transdermal Delivery of Dopamine Agonists for Treatment of ‘OFF’ Periods in Parkinsons Disease

(M1430-03-17) Targeted Antiretroviral Therapy Using Controlled Release Polymeric Nanoparticles for Brain Viral Load Reduction and Management of HIV Associated Neurocognitive Disorder (HAND)

(T1430-03-18) Balancing Particle Stability and Permeability Advantages of High Drug Loading Amorphous Nanoparticle Formulations

(M1430-03-18) Optimizing Semi-Solid Extrusion 3D Printed Hydrochlorothiazide Tablets: The Role of Rheological Properties and Drying Methods on Structure and Appearance

(M1430-05-25) Hydrolysis of Cellulose Acetate Phthalate and Hydroxypropyl Methylcellulose Phthalate in Amorphous Solid Dispersions

(T1430-05-25) Monitoring the Dissolution Behavior of Dissolving Microneedles by UV-Vis Imaging System

(M1430-05-26) Rapid and Reliable Nitrite Content Analysis in Pharmaceutical Excipients with the ACQUITY^TM QDa^TM II Mass Detector

(T1430-05-27) Evaluate pH-Triggered and Sustainable Drug Release for Dendrimer-Based Formulations of STAT3 Inhibitor

(M1430-05-28) Development of 3D Printed Tablets of Weakly Acidic Drug-Flurbiprofen by Acid-Base Super-Solubilization at Lower Extrusion Temperature and Improved Printability

(T1430-05-28) Modification of Microenvironmental pH of Nanoparticles for Enhanced Solubility and Oral Bioavailability of Poorly Water-Soluble Celecoxib

(M1430-05-29) Addressing the Opioid Crisis: Assessing Abuse-Deterrent Formulations Utilizing Ion-Exchange Resin Complexation Processed via Twin-Screw Granulation for Improved Safety and Effectiveness

(T1430-05-29) Critical System Suitability Test Established in Regulatory Analytical Procedures for Testing Organic Impurities in Drug Substance and Drug Product and Relevant Changes in Recently Revised USP < 621 >

(M1430-05-30) Formulation Development of PEGylated Deferoxamine Carbon Nanoparticles Gel for Topical Application

(T1430-05-30) Preparation and Characterization of Nanoemulsion Formulation for Andrographolide to Improve its Oral Bioavailability Characteristics

(T1430-07-38) Active Targeting of Colorectal Cancer Using Chemotherapy-Loaded Nanoparticles Functionalized with Folate Receptor-α (FRα) Ligand, Pemetrexed

(M1430-07-38) Nanotechnological Approach to Cannabidiol Delivery: Production and Characterization of Microemulsion for Oral Administration

(T1430-07-39) Improving the Bioavailability of Fenofibrate by Atomic Layer Coating

(M1430-07-39) Targeting Resistant Pathogens: The Promise of Vancomycin-Silver Nanoparticle Hybrids Against Vancomycin-Intermediate Staphylococcus Aureus (VISA)

(M1430-07-40) Mechanistic PBPK Modelling of Itraconazole Oral Solutions: Evaluating HP-β-CD Impact on Solubility and Drug-Drug Interactions

(T1430-07-41) Fenofibrate Microparticles for Long Lasting Therapy of Posterior Eye Disease

(M1430-07-41) Functional Coatings with Cellulose Acetate Grade Combinations in Osmotic Devices – Process Optimization and Release Modulation of Metoprolol Succinate

(T1430-09-49) Preparation and Evaluation of 5-Fluorouracil Loaded Oil In Water Emulgel for Anti-Adhesion and Cancer Chemotherapy

(M1430-09-49) Remote Encapsulation of Exenatide in PLGA Microspheres Using Cationic Excipients

(T1430-09-50) Amelioration of Drug-Induced Nephrotoxicity Using Ganglioside Liposomes

(M1430-09-50) Creating Personalized 3D-Printed Finger Splints with Ibuprofen-Loaded Nanofibers for Quicker Healing Using CT Scans

(M1430-09-51) Aerosolizable Drug Loaded Superparamagnetic Iron Oxide Nanoparticle Theranostic for Pulmonary Tuberculosis

(T1430-09-51) Feasibility of Controlled Nitric Oxide Generation via Ascorbate Induced Chemical Reduction of Nitrite Ions

(M1430-09-52) Development of Dry Powder Formulation of PAV-104 for Pulmonary Drug Delivery

(T1430-09-52) Encorafenib and Trametinib Co-Loaded Nanoparticles as a Therapy for Colon Cancer

(T1530-01-01) Proven New Sustainable Eco-Friendly Packaging for Challenging Formulation Compositions

(M1530-01-02) 2-Stage Dissolution Method for Drug Release Testing of Sodium Oxybate Extended-Release Drug Product LUMRYZ^TM

(T1530-01-02) Development of a pH-Responsive Nanocarrier to Deliver Phenelzine for Prostate Cancer Treatment

(T1530-01-03) Influence of Composition Variation on Solubility and Release Profile of CBD Self-Emulsifying Drug Delivery System

(M1530-01-03) Targeted Cell-Penetrating Peptide-Drug Conjugates for the Treatment of Pancreatic Cancer

(T1530-01-05) Development of Clofazimine Lipid-Based SEDDS with High Drug Loading Using Digestion Products of Long-Chain Triglyceride

(M1530-01-05) Evaluation of a TiO2-Free PVA-Based Film Coating System with Improved Opacity and Color Uniformity

(T1530-01-06) Use of In Silico Models to Predict In Vitro Skin Flux and Comparison with Experimental Results for Transdermal Drug Delivery

(T1530-03-13) Delineating the Effect of Commonly Used Surfactant/Cosurfactant Compositions Affecting the Dispersion Characteristics of Aqueous-Based Nasal Sprays

(T1530-03-14) Importance of β Cyclodextrin Substitution Level and Type for Solubilization and Stabilization of Poorly Soluble APIs in Parenteral Dosage Forms

(M1530-03-15) Biopredictive Dissolution of Budesonide Enteric Pellets under Simulated Fasted Intake Conditions

(T1530-03-15) In Vitro Evaluation of Drug Concentrations in the Contents of Upper Gastrointestinal Lumen During the Post-Disintegration Period in the Fed State: Design and Performance Assessment of BioGITfed

(M1530-03-16) Development and Optimization of Oral Dissolving Film Formulation Containing Psilocybin

(T1530-03-17) Advancing Cancer Immunotherapy: Real-Time Immune Profiling and Cytokine Monitoring with an Integrated Biosensing Platform

(M1530-03-17) Downstreaming Amorphous Solid Dispersions: Direct Compression of Free-Flowing Telmisartan Microparticles

(T1530-03-18) Physicochemical Characterization and In Vitro/Ex Vivo Evaluation of Transdermal Gels of Baricitinib for Rheumatoid Arthritis

(T1530-05-25) Decorated Drug Nanocrystals as Highly-Loaded Trojan Horses for Nose-to-Brain Delivery in Cerebral Malaria

(M1530-05-25) Enhanced Understanding of the Relationship between Drug Product Structure and Its Performance by Using Modeling and Simulation - A Case Study with Dapsone Topical Gel

(T1530-07-37) Direct Compression and Continuous Wet Granulation for Controlled Release Minitablets

(M1530-07-38) Twin Screw Melt Granulation: Enhancing Solubility and Release Profile of Simvastatin Using Miscible and Immiscible Polymer Blends

(M1530-07-39) Compression-Induced Destabilization in Chlorpropamide-PVPVA Amorphous Solid Dispersions

(T1530-07-39) Overcoming Incompatibility between Moxifloxacin and Carbopol^®934 Polymers in Ophthalmic Drug Delivery Systems

(T1530-07-40) Design and Enhanced Permeability of Sublingual Tablets Containing Leuprolide Nanoparticles With or Without Permeation Enhancers

(M1530-07-40) Mannitol vs Lactose in Twin Screw Continuous Wet Granulation Using New Binder

(T1530-07-41) A Tunable, Biodegradable Drug Delivery Platform with Hydralese^TM for Long-Acting Implants

(M1530-07-41) Preparation and Characterization of Hydrogel Microneedles Using Gantrez®S-97 and Hyaluronic Acid

(T1530-09-48) Copovidone-Based Spray Dried Amorphous Solid Dispersions: Investigation of Drug Loadings and the Limit of Congruency

(T1530-09-49) Untangling the Interplay of Drug Solubility, Microstructure, and Polymer Behavior on the Performance of Commercial Controlled Release Microsphere Products

(T1530-09-50) Development of an In Vitro Release Test to Characterize Onivyde Using Bio-Beads SM-2 Resin

(M1530-09-50) Exploring Manufacturing Techniques for Enhancing the Solubility of Fenbendazole: A Comparative Study of Hot-Melt Extrusion, Spray Drying, and KinetiSol® Processing

(T1530-09-51) Formulation and Characterization of Quetiapine Fumarate Floating Bioadhesive Tablets Using TSMG

(M1530-09-51) Influence of Lyophilization Process Conditions on Crystallization Behavior and Formulation Stability of Doxycycline for Injection

(T1530-09-52) Leveraging an Algorithm-Based Digital Platform for Excipient selection facilitating Formulation Development of Poorly Soluble Active Pharmaceutical Ingredients

(M1530-09-52) Mass Transport Modeling and In Silico Formulation of Osmotic Controlled Release Tablets with Microscopy-Based Digital Twins

(T1530-10-54) Development of Hot-Melt Extruded Implants Using Polycaprolactone as a Biodegradable Polymer

(T1530-10-55) 3D Printed Container System for Delayed Release

(M1530-10-55) Using Dissolution-Permeation Systems and In Silico PBPK Modeling for Food Effect Prediction of a BCS Class II Drug

(T1530-10-56) Development of In Vitro/In Vivo Correlation for Long-Acting Suspensions via Bootstrapping

(M1530-10-56) Enhancing the Solubilization and Permeation of Fenofibrate: A Comparative Study of Free Form, PEG and SEDDS Formulations

(T1530-10-57) Impact of Counterions on the Performance of Spray-Dried Dispersions of Weak Base Drugs

(M1530-10-57) Innovative Moisture Activated Dry Granulation (MADG) with Mesoporous Silica vs Wet Granulation: A Comparative Study

(M1530-10-58) In Vivo Bioavailability Enhancement of Abiraterone Acetate Dispersome^® Formulations

(T1530-10-58) Optimizing Mucoadhesive Properties of Oral Thin Films: The Impact of Substrate Selection on Adhesive Force and Residence Time